Addison Advisors’s ResMed RMD Stock Holding History

Addison Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$975	Hold	5	–	–	﹤0.01%	623
2026 Q1	$1.12K	Hold	5	–	–	﹤0.01%	881
2025 Q4	$1.21K	Hold	5	–	–	﹤0.01%	821
2025 Q3	$1.37K	Hold	5	–	–	﹤0.01%	801
2025 Q2	$1.29K	Hold	5	–	–	﹤0.01%	806
2025 Q1	$1.12K	Hold	5	–	–	﹤0.01%	778
2024 Q4	$1.14K	Hold	5	–	–	﹤0.01%	779
2024 Q3	$1.22K	Hold	5	–	–	﹤0.01%	761
2024 Q2	$958	Buy	+5	New	+$1.01K	﹤0.01%	720
2023 Q1	–	Sell	-3	Closed	-$624	–	758
2022 Q4	$624	Hold	3	–	–	﹤0.01%	658
2022 Q3	$1K	Hold	3	–	–	﹤0.01%	645
2022 Q2	$1K	Hold	3	–	–	﹤0.01%	640
2022 Q1	$1K	Hold	3	–	–	﹤0.01%	668
2021 Q4	$1K	Buy	+3	New	+$778	﹤0.01%	625

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Addison Advisors's RMD Position: Q2 2026 in Review

Addison Advisors held its ResMed (RMD) position steady in Q2 2026 at 5 shares worth $975. The position accounts for ﹤0.01% of the portfolio, ranked #623.

Addison Advisors first reported a position in RMD in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.37K in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Addison Advisors held 5 shares of ResMed worth $975 as of Q2 2026.
Addison Advisors left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of Addison Advisors's portfolio in Q2 2026, its #623 holding.
Addison Advisors first reported a position in ResMed in Q4 2021 and has held it in 14 quarters since.
Addison Advisors's ResMed position peaked at $1.37K in Q3 2025.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.